Schizophrenia Research
Volume 92, Issue 1 , Pages 90-94 , May 2007

Risperidone augmentation for schizophrenia partially responsive to clozapine: A double-blind, placebo-controlled trial

  • Oliver Freudenreich

      Affiliations

    • Massachusetts General Hospital Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States
    • Harvard Medical School, Boston, MA, United States
    • Boston University School of Medicine, Boston, MA, United States
    • Corresponding Author InformationCorresponding author. MGH Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States. Tel.: +1 617 912 7835; fax: +1 617 723 3919.
    • ,
  • David C. Henderson

      Affiliations

    • Massachusetts General Hospital Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States
    • Harvard Medical School, Boston, MA, United States
    • ,
  • Jared P. Walsh

      Affiliations

    • Massachusetts General Hospital Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States
    • ,
  • Melissa A. Culhane

      Affiliations

    • Massachusetts General Hospital Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States
    • Harvard Medical School, Boston, MA, United States
    • ,
  • Donald C. Goff

      Affiliations

    • Massachusetts General Hospital Schizophrenia Program, Freedom Trail Clinic, 25 Staniford St., 2nd Floor, Boston, MA 02114, United States
    • Harvard Medical School, Boston, MA, United States

Received 6 October 2006 ,Revised 14 December 2006 ,Accepted 20 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Funding for this trial was provided by a grant from the Stanley Medical Research Institute (Oliver Freudenreich).

PII: S0920-9964(07)00032-1

doi: 10.1016/j.schres.2006.12.030

Schizophrenia Research
Volume 92, Issue 1 , Pages 90-94 , May 2007

Article Tools

* Image Usage & Resolution